Status:

WITHDRAWN

The Effect of Clevidipine on Intracranial Pressure and Cerebral Perfusion Pressure (CCP) in Brain Injured Patients

Lead Sponsor:

Columbia University

Collaborating Sponsors:

The Medicines Company

Conditions:

Hypertension

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Patients with acute brain injury are at risk for complications such as increased pressure in the brain (intracranial pressure (ICP)), decreased blood flow, bleeding, and brain swelling (cerebral edema...

Detailed Description

This is an open-label, single arm, single center study in patients with hypertension in the setting of an acute brain injury. Approximately 15 patients admitted to the Columbia University Neurocritica...

Eligibility Criteria

Inclusion

  • Coma (Glasgow Coma Scale (GCS) less than or equal to 8) due to any cause
  • Male and Female patients \> 18 years.
  • Mechanically ventilated
  • Functional multimodality neuromonitoring bundle (intracranial pressure (ICP) monitor, Hemedex, Licox, and microdialysis) placed in the course of routine clinical management
  • Patient is hypertensive at the time of enrollment (CPP \>100 mm Hg and/or SBP \>180mmHg) and the decision has been made to start clevidipine butyrate in order to maintain CPP within 70-90 mm Hg and/or SBP \<180mmHg
  • Patient has a minimum of 60 min of baseline brain multimodality monitoring prior to initiation of clevidipine -

Exclusion

  • Absence of negative pregnancy test in women of child-bearing potential.
  • FiO2 \>50%
  • Unable to maintain stable sedative infusion rates for 4 hours
  • Unable to maintain stable ventilator setting for 4 hours
  • Unable to maintain stable insulin infusion rates for 4 hours
  • Patient is currently receiving nicardipine infusion
  • Allergy to soybean oil or lecithin
  • Participation in other clinical research studies involving the evaluation of other investigational drugs or devices within 30 days of enrollment.

Key Trial Info

Start Date :

November 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 19 2012

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01526876

Start Date

November 1 2011

End Date

December 19 2012

Last Update

July 17 2017

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.